Geometry.Net - Health_Conditions: Juvenile Rheumatoid Arthritis

Autoimmune Diseases/Rheumatology
National Jewish offers a full range of adult rheumatology services and ajuvenile rheumatoid arthritis Clinic juvenile rheumatoid arthritis.
http://www.njc.org/diseases/dt5.html
Disease Category Listing (378): Rheumatoid Arthritis (Pediatric)
Phoenix; Phoenix Center for Clinical Research (PCCR) Are you or a loved one interestedin participating in a clinical trial for juvenile rheumatoid arthritis?
http://www.centerwatch.com/patient/studies/cat378.html
Health Topics A - Z On Medbroadcast.com
juvenile rheumatoid arthritis The Arthritis SocietyJuvenile rheumatoidarthritis MEDLINEplus-juvenile rheumatoid arthritis. HOME
http://www.medbroadcast.com/health_topics_a_z/index.shtml?j.html
HealthlinkUSA Juvenile Rheumatoid Arthritis Links
Information on juvenile rheumatoid arthritis. Recommended. Click here for page 1 ofjuvenile rheumatoid arthritis information from the HealthlinkUSA directory.
http://www.healthlinkusa.com/399ent.htm
ClinicalTrials.gov - Linking Patients To Medical Research: Results
Search results for juvenile rheumatoid arthritis ALLFIELDS are shown below.Show all trials, including those no longer recruiting patients.
http://www.clinicaltrials.gov/ct/gui/action/SearchAction?term=Juvenile Rheumatoi
ClinicalTrials.gov - Linking Patients To Medical Research: Results
Here are studies 1 to 50. 1. Recruiting, Infliximab to Treat Children withjuvenile rheumatoid arthritis Condition juvenile rheumatoid arthritis.
http://www.clinicaltrials.gov/ct/gui/action/SearchAction?term=Arthritis
HealingWell.com - Medifocus Guides - Juvenile Rheumatoid Arthritis
Research your illness with an indepth Medifocus Guide to juvenile rheumatoid arthritis. Whatare the most common symptoms of juvenile rheumatoid arthritis?
http://www.healingwell.com/medcenter/juvenile_rheumatoid_arthritis.asp

Extractions: Chronic arthritis in childhood is not a single entity but a heterogeneous group of disorders. The term juvenile chronic arthritis (JCA) had been common in Europe while Juvenile Rheumatoid Arthritis (JRA) was used in North America. In 1997, these terms were discarded for a broader, universal term, Juvenile Idiopathic Arthritis (JIA). JIA defines arthritis beginning at less than 16 years of age and persisting for at least 6 weeks and with no known cause. Rheumatoid factor positive polyarthritis (with RF testing positive on at lest two occasions three months apart) include approximately 10% of children with polyarticular JIA. The majority of affected children are adolescent girls who develop symmetrical polyarthritis affectingmany joints but usually including the small joints of their hands. This will frequently progress to an erosive arthropathy with a disease course similar to that of adult rheumatoid arthritis. This is essentially early onset 'adult-type' rheumatoid arthritis. As with adults, treatment of Juvenile Arthritis is aimed at controlling inflammation and minimizing its effects on the joints. Localized joint problems can be minimized by good early control of the inflammatory process. Drug treatment is combined with physical therapy and the judicious use of splinting to maintain correct joint position and function.
Keeping A Secret: A Story About Juvenile Rheumatoid Arthritis
Keeping A Secret A Story About juvenile rheumatoid arthritis Elizabeth MurphyMelasIllustrated by April Hartmann. Why can't Jennifer play soccer or jump rope?
http://www.healthpress.com/juvenilerheumatoidarthritis.html

Extractions: Select a Category Cardiology Children's Books Disabilities General Practice Grief Integrative Medicine Men's Health Ob Gyn Oncology Parenting Pediatrics Pet Health Professional Texts Psychology Reference Texts Seniors Spanish Language Women's Health Complete Title List Search Home Page Keeping A Secret: Illustrated by April Hartmann Why can't Jennifer play soccer or jump rope? Any child with a chronic disease will relate to this young girl coming to terms with her diagnosis and treatment of juvenile rheumatoid arthritis, and the manner in which she shares this news with her friends. Warning Signs of Arthritis
Rheumatoid Arthritis
Links, information, message board forum and support for sufferers of this disease.Category Health Conditions and Diseases Arthritis Support Groups juvenile rheumatoid arthritis http//www.seffera.net/jra/index.html Arthritis Foundationhttp//www.arthritis.org/ JRA World juvenile arthritis support http
http://badler126.homestead.com/ra.html
EMedicine - Uveitis, Juvenile Rheumatoid Arthritis : Article By Manolette R Roqu
Uveitis, juvenile rheumatoid arthritis Approximately 6% of all casesof uveitis arise in children. Uveitis, juvenile rheumatoid arthritis.
http://www.emedicine.com/oph/topic675.htm

Extractions: (advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Ophthalmology Iris And Ciliary Body Last Updated: September 20, 2001 Rate this Article Email to a Colleague Synonyms and related keywords: JRA-associated uveitis, JRA uveitis AUTHOR INFORMATION Section 1 of 11 Author Information Introduction Clinical Differentials ... Bibliography Author: Manolette R Roque, MD , Chief of Service, Immunology and Uveitis Service, Consulting Staff, Cornea and Refractive Surgery Service, QC Eye Center, Cavite Eye and ENT Center, Makati Eye Laser Center Coauthor(s): Elisabetta Miserocchi, MD , Fellow in Immunology and Uveitis Service, Department of Ophthalmology, Harvard Medical School; C Stephen Foster, MD, FACS , Director of Immunology and Uveitis Service, Professor, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School Manolette R Roque, MD, is a member of the following medical societies:
Juvenile Rheumatoid Arthritis
juvenile rheumatoid arthritis (JRA) is arthritis that causes joint inflammationand stiffness for more than 6 weeks in a child of 16 years of age or less.
http://healthlink.mcw.edu/article/926045442.html

Extractions: Subscribe now >> Arthritis means joint inflammation, and refers to a group of diseases that cause pain, swelling, stiffness and loss of motion in the joints. "Arthritis" is often used as a more general term to refer to the more than 100 rheumatic diseases that may affect the joints but can also cause pain, swelling, and stiffness in other supporting structures of the body such as muscles, tendons, ligaments, and bones. Some rheumatic diseases can affect other parts of the body, including various internal organs. Children can develop almost all types of arthritis that affect adults, but the most common type of arthritis that affects children is juvenile rheumatoid arthritis. Juvenile rheumatoid arthritis (JRA) is arthritis that causes joint inflammation and stiffness for more than 6 weeks in a child of 16 years of age or less. Inflammation causes redness, swelling, warmth, and soreness in the joints, although many children with JRA do not complain of joint pain. Any joint can be affected and inflammation may limit the mobility of affected joints.
New Drug Therapy For Juvenile Rheumatoid Arthritis
Once ravaged by juvenile rheumatoid arthritis, the girl now ridesa bicycle, and walks to the park and back on her own.
http://healthlink.mcw.edu/article/933196875.html

Extractions: Subscribe now >> It's hard to believe that not long ago, a seven-year-old Wisconsin girl was in such constant pain that she used a tricycle to move between classrooms at school, she could not walk across the street or even use coloring books. Once ravaged by juvenile rheumatoid arthritis (JRA), the girl now rides a bicycle, walks to the park and back on her own, rough-houses with her older brother, and even runs and skips like a little dervish. It's all thanks to a new drug therapy she received under the care of James Nocton, MD , assistant professor of pediatrics at the Medical College of Wisconsin. Dr. Nocton is based at Children's Hospital of Wisconsin, an affiliate of MCW. The little girl was one of the first 50 juvenile rheumatoid arthritis patients in the country to try Enbrel, a genetically engineered human protein which seems to halt progress of the disease in some patients. She began taking Enbrel as part of a national clinical trial by the U.S. Food and Drug Administration and the drug's manufacturer, Immunex Corp. Children's Hospital is one of nine participating test sites.
Juvenile Rheumatoid Arthritis
juvenile rheumatoid arthritis is an inflammation of the synovial membrane and isa debilitating disease. Read this article about juvenile rheumatoid arthritis.
http://www.arthritis-glucosamine.net/arthritis/juvenile-rheumatoid-arthritis.htm
Ask NOAH About: Arthritis And Rheumatic Disease
Disease Arthritis Foundation Still's Disease - Arthritis Insight Still's Disease(Systemic-Onset juvenile rheumatoid arthritis) - MedicineNet Systemic Lupus
http://www.noah-health.org/english/illness/arthritis/arthritis.html
Wyeth: News & Announcements
on the companies' commitment to release ENBREL supply as it becomes available forthese rheumatoid arthritis, juvenile rheumatoid arthritis, and psoriatic
http://www.wyeth.com/news/Pressed_and_Released/pr12_02_2002_08_12_03.asp

Extractions: View News and Announcements Archive THOUSAND OAKS, Calif., and RADNOR, Penn., December 2, 2002 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that supply of the breakthrough biologic, ENBREL( (etanercept), has been offered over the past 8 weeks to more than 40,000 patients on the ENBREL Prospective Patient List.Â These patients and their physicians are being notified that they may now order ENBREL. "We are pleased to be able to deliver on the companies' commitment to release ENBREL supply as it becomes available for these rheumatoid arthritis, juvenile rheumatoid arthritis, and psoriatic arthritis patients," said Kevin Young, vice president and general manager of Amgen's Inflammation Business Unit.Â "We have experienced improved efficiencies at the current ENBREL manufacturing facility that have helped enable us to make this large-scale offering of supply to patients." "This step is significant in that it opens the door for more patients to benefit from ENBREL, the only TNF receptor therapy distinguished by five years of data supporting its consistent and sustained efficacy and long-term tolerability," said Joseph Mahady, president North America, Wyeth Pharmaceuticals.Â
Wyeth: News & Announcements
Over one million patients with rheumatoid arthritis, juvenile rheumatoid arthritisand psoriatic arthritis in the United States are potential candidates for
http://www.wyeth.com/news/Pressed_and_Released/pr12_26_2002_08_44_34.asp

Extractions: View News and Announcements Archive THOUSAND OAKS, Calif., and RADNOR, Pa., Dec. 23, 2002 - Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration (FDA) has approved Amgen's Rhode Island manufacturing facility for ENBREL (etanercept).Â With this approval, significant supply of ENBREL is now available for patients since production has been underway at the facility for many months.Â Over one million patients with rheumatoid arthritis, juvenile rheumatoid arthritis and psoriatic arthritis in the United States are potential candidates for this breakthrough biologic. "Working in close harmony with the FDA, we are delighted to beat our expected timelines and make ENBREL available to patients as quickly as possible," said Kevin Sharer, Amgen's Chairman and CEO.Â "The facility is among the most advanced cell culture manufacturing centers in the world and is expected to more than satisfy the expanding patient demand for this unique therapy." "We believe this news, combined with five years of outstanding clinical performance and tolerability, will encourage physicians to once again make ENBREL their first choice for patients," said Joseph Mahady, president, North America, Wyeth Pharmaceuticals.
AOA | Juvenile Arthritis
The most common form of the disease among children is juvenile rheumatoidarthritis. juvenile rheumatoid arthritis (JRA) affects the entire body.
http://www.aoa-net.org/Consumers/juvarthritis.htm

Extractions: Known cases of arthritis date as far back as 4500 BC with Native Americans in the Tennessee and Green Rivers region. Times have changed, yet arthritis persists. Today, approximately 300,000 children face the challenges of arthritis or rheumatic diseases with millions of other children at risk. According to the Arthritis Foundation, that means nearly 3 of every 1,000 children are living with a form of arthritis. The most common form of the disease among children is juvenile rheumatoid arthritis. Juvenile rheumatoid arthritis (JRA) affects the entire body. Characterized by inflammation of the membrane lining the joint, JRA invades the synovium, the joint lining, and damages bone and cartilage by releasing enzymes that digest the bone and cartilage. JRA may affect growth during active periods of the disease. Onset occurs between the ages of 2 to 5 years of age and 9 to 12 years of age. Girls are also at a higher risk than boys. For more information on JRA or other forms of juvenile arthritis www.arthritis.org
Juvenile (Chronic/Rheumatoid) Arthritis
juvenile rheumatoid arthritis; American Juvenile Arthritis Organization; Arthritis,Juvenile Rheumatoid; juvenile rheumatoid arthritis; Related Books. HOME
http://www.bdid.com/arthbooks.htm
SUNY Upstate Medical University: Health Care Providers
Infectious Disease Center, Pediatrics Kidney Disorders (Pediatrics) Joint Centerfor Total Joint Replacement juvenile rheumatoid arthritis Clinic KNOT (Kids
http://www.upstate.edu/homepage/healthproviders.shtml
University Hospital: Pediatric Services
Clinical, Programs. juvenile rheumatoid arthritis Clinic. UniversityHospital 750 East Adams St. (315) 4645420. Specialists in juvenile
http://www.upstate.edu/peds/uhpeds/programs/juvenile.shtml

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

41-60 of 98 Back | 1 | 2 | 3 | 4 | 5 | Next 20